Taiwan FDA registration 189bba49f00fb5989c51927f1c2fc9b4

Vitex biochemical products antistreptolysin O reagent

TW: 維特司生化產品抗鏈球菌溶血素Ｏ試劑

Taiwan·Risk Class 2·ORTHO-CLINICAL DIAGNOSTICS, INC.;; ORTHO-CLINICAL DIAGNOSTICS, INC·Registered Jul 17, 2006 – Jul 17, 2026Expired

Registration details

Analysis ID: 189bba49f00fb5989c51927f1c2fc9b4
Customs Code: DHA00601722502

Company information

Manufacturer: ORTHO-CLINICAL DIAGNOSTICS, INC.;; ORTHO-CLINICAL DIAGNOSTICS, INC
Manufacturer Country: United States
Authorized Representative: DKSH TAIWAN LTD.

Product details

Intended Use: Used to measure the concentration of antistreptolysin O in serum or plasma.　　
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.3720 鏈球菌屬胞外酶試劑
Import Information: import

Dates and status

Registration Date: Jul 17, 2006
Expiry Date: Jul 17, 2026

About this record

Access comprehensive regulatory information for Vitex biochemical products antistreptolysin O reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 189bba49f00fb5989c51927f1c2fc9b4 and manufactured by ORTHO-CLINICAL DIAGNOSTICS, INC.;; ORTHO-CLINICAL DIAGNOSTICS, INC. The authorized representative in Taiwan is DKSH TAIWAN LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.